Terms and Conditions

A summary of the terms of use for this site and the conditions and licensing for reproduction Read more

Accessibility

Read our policy on accessibility for our site Read more

Our history

Read more

Our impact

Read more

Support us

Read more

Text styles

Text styles for the site Read more

Corporate partnerships

Solving Kids’ Cancer is hugely grateful for the dedication, enthusiasm and hard work of corporate companies and their staff. By partnering with Solving Kids' Cancer, these companies help to fund our vital family support and research work. Read more

Fundraising resources

Order and download our fundraising resources to raise funds for children affected by neuroblastoma Read more

Research policies

Solving Kids' Cancer supports clear Association of Medical Research Charities (AMRC) policies on research in universities and animal research. Read more

Funding partners

We have established links with like-minded advocates and charities across Europe and the US, and seek to work collaboratively wherever possible. Read more

Research funding award process

In April each year Solving Kids’ Cancer will issue a Request for Applications (RFA) inviting researchers to submit their ideas to us as part of a Competitive Funding Call process. Read more

Scientific Advisory Board

Solving Kids’ Cancer’s Scientific Advisory Board (SAB) has responsibility for providing expert advice, guidance, and input with regards to the charity’s research strategy, and for overseeing the development of a formal, structured, scientifically robust, and accredited grant award process. Read more

Research

We are committed to bringing more, better and less toxic treatment options to the UK for children fighting neuroblastoma now. Through this, we are determined to advance science and find a cure for future generations. Read more

Other sources of help

It’s important to Solving Kids’ Cancer that we work closely and collaborate with other charities that offer support, distribute useful information and fund research in neuroblastoma. Read more